ANIX
ANIX
NASDAQ · Biotechnology

Anixa Biosciences Inc

$2.81
+0.23 (+8.91%)
As of Apr 1, 3:06 PM ET ·
Financial Highlights (FY 2025)
Revenue
12.06M
Net Income
2.28M
Gross Margin
60.8%
Profit Margin
18.9%
Rev Growth
+16.3%
D/E Ratio
1.56
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 60.8% 60.8% 60.8%
Operating Margin 18.9% 18.4% 20.4%
Profit Margin 18.9% 19.3% 20.8%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 12.06M 11.02M 11.79M
Gross Profit 7.32M 6.69M 7.16M
Operating Income 2.28M 2.03M 2.40M
Net Income 2.28M 2.12M 2.45M
Gross Margin 60.8% 60.8% 60.8%
Operating Margin 18.9% 18.4% 20.4%
Profit Margin 18.9% 19.3% 20.8%
Rev Growth +16.3% -0.5% +13.7%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 49.37M 44.66M 49.52M
Total Equity 31.56M 33.14M 31.76M
D/E Ratio 1.56 1.35 1.56
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 3.37M 3.22M 3.75M
Free Cash Flow 1.70M 2.02M 1.47M